New antipsychotic prescription and recurrent infections among adult sepsis survivors : A population-based cohort study
© 2023 John Wiley & Sons Ltd..
PURPOSE: Antipsychotic agents, which may increase the risk of infection through dopaminergic dysregulation, are prescribed to a fraction of patients following critical illness. We compared the rate of recurrent sepsis among patients who filled a prescription for antipsychotics with high- or low-D2 affinity.
METHODS: Population-based cohort with active comparator design. We included sepsis survivors older than 65 years with intensive care unit admission and new prescription of antipsychotics in Ontario 2008-2019. The primary outcome were recurrent sepsis episodes within 1 year of follow-up. Patients who filled a prescription within 30 days of hospital discharge for high-D2 affinity antipsychotics (e.g., haloperidol) were compared with patients who filled a prescription within 30 days of hospital discharge for low-D2 affinity antipsychotics (e.g., quetiapine). Multivariable zero-inflated Poisson regression models with robust standard errors adjusting for confounding at baseline were used to estimate incidence rate ratios (IRR) and 95% confidence intervals (CI).
RESULTS: Overall, 1879 patients filled a prescription for a high-D2, and 1446 patients filled a prescription for a low-D2 affinity antipsychotic. Patients who filled a prescription for a high-D2 affinity antipsychotic did not present a higher rate of recurrent sepsis during 1 year of follow-up, compared with patients who filled a prescription for a low-D2 affinity antipsychotic (IRR: 1.12; 95% CI: 0.94, 1.35).
CONCLUSIONS: We did not find conclusive evidence of a higher rate of recurrent sepsis associated with the prescription of high-D2 affinity antipsychotics (compared with low-D2 affinity antipsychotics) by 1 year of follow-up in adult sepsis survivors with intensive care unit admission.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:33 |
---|---|
Enthalten in: |
Pharmacoepidemiology and drug safety - 33(2024), 2 vom: 01. Feb., Seite e5747 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Ferraris, Augusto [VerfasserIn] |
---|
Links: |
---|
Themen: |
Antipsychotic Agents |
---|
Anmerkungen: |
Date Completed 19.02.2024 Date Revised 19.02.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1002/pds.5747 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM366168800 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM366168800 | ||
003 | DE-627 | ||
005 | 20240219231938.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231227s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1002/pds.5747 |2 doi | |
028 | 5 | 2 | |a pubmed24n1299.xml |
035 | |a (DE-627)NLM366168800 | ||
035 | |a (NLM)38126218 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Ferraris, Augusto |e verfasserin |4 aut | |
245 | 1 | 0 | |a New antipsychotic prescription and recurrent infections among adult sepsis survivors |b A population-based cohort study |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 19.02.2024 | ||
500 | |a Date Revised 19.02.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2023 John Wiley & Sons Ltd. | ||
520 | |a PURPOSE: Antipsychotic agents, which may increase the risk of infection through dopaminergic dysregulation, are prescribed to a fraction of patients following critical illness. We compared the rate of recurrent sepsis among patients who filled a prescription for antipsychotics with high- or low-D2 affinity | ||
520 | |a METHODS: Population-based cohort with active comparator design. We included sepsis survivors older than 65 years with intensive care unit admission and new prescription of antipsychotics in Ontario 2008-2019. The primary outcome were recurrent sepsis episodes within 1 year of follow-up. Patients who filled a prescription within 30 days of hospital discharge for high-D2 affinity antipsychotics (e.g., haloperidol) were compared with patients who filled a prescription within 30 days of hospital discharge for low-D2 affinity antipsychotics (e.g., quetiapine). Multivariable zero-inflated Poisson regression models with robust standard errors adjusting for confounding at baseline were used to estimate incidence rate ratios (IRR) and 95% confidence intervals (CI) | ||
520 | |a RESULTS: Overall, 1879 patients filled a prescription for a high-D2, and 1446 patients filled a prescription for a low-D2 affinity antipsychotic. Patients who filled a prescription for a high-D2 affinity antipsychotic did not present a higher rate of recurrent sepsis during 1 year of follow-up, compared with patients who filled a prescription for a low-D2 affinity antipsychotic (IRR: 1.12; 95% CI: 0.94, 1.35) | ||
520 | |a CONCLUSIONS: We did not find conclusive evidence of a higher rate of recurrent sepsis associated with the prescription of high-D2 affinity antipsychotics (compared with low-D2 affinity antipsychotics) by 1 year of follow-up in adult sepsis survivors with intensive care unit admission | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a antipsychotic agents | |
650 | 4 | |a drug exposure | |
650 | 4 | |a drug-related side effects and adverse reactions | |
650 | 4 | |a infection | |
650 | 4 | |a pharmacoepidemiology | |
650 | 4 | |a sepsis | |
650 | 7 | |a Antipsychotic Agents |2 NLM | |
700 | 1 | |a Szmulewicz, Alejandro G |e verfasserin |4 aut | |
700 | 1 | |a Burry, Lisa |e verfasserin |4 aut | |
700 | 1 | |a Phipps, Amanda |e verfasserin |4 aut | |
700 | 1 | |a Wunsch, Hannah |e verfasserin |4 aut | |
700 | 1 | |a Scales, Damon C |e verfasserin |4 aut | |
700 | 1 | |a Angriman, Federico |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Pharmacoepidemiology and drug safety |d 1996 |g 33(2024), 2 vom: 01. Feb., Seite e5747 |w (DE-627)NLM091631106 |x 1099-1557 |7 nnns |
773 | 1 | 8 | |g volume:33 |g year:2024 |g number:2 |g day:01 |g month:02 |g pages:e5747 |
856 | 4 | 0 | |u http://dx.doi.org/10.1002/pds.5747 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 33 |j 2024 |e 2 |b 01 |c 02 |h e5747 |